Chapter/Section Purchase

1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Tourette Syndrome Treatment Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Antipsychotics
1.2.3 Non Antipsychotics
1.3 Market by Application
1.3.1 Global Tourette Syndrome Treatment Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Children
1.3.3 Adult
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Tourette Syndrome Treatment Market Perspective (2017-2028)
2.2 Tourette Syndrome Treatment Growth Trends by Region
2.2.1 Tourette Syndrome Treatment Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Tourette Syndrome Treatment Historic Market Size by Region (2017-2022)
2.2.3 Tourette Syndrome Treatment Forecasted Market Size by Region (2023-2028)
2.3 Tourette Syndrome Treatment Market Dynamics
2.3.1 Tourette Syndrome Treatment Industry Trends
2.3.2 Tourette Syndrome Treatment Market Drivers
2.3.3 Tourette Syndrome Treatment Market Challenges
2.3.4 Tourette Syndrome Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Tourette Syndrome Treatment Players by Revenue
3.1.1 Global Top Tourette Syndrome Treatment Players by Revenue (2017-2022)
3.1.2 Global Tourette Syndrome Treatment Revenue Market Share by Players (2017-2022)
3.2 Global Tourette Syndrome Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Tourette Syndrome Treatment Revenue
3.4 Global Tourette Syndrome Treatment Market Concentration Ratio
3.4.1 Global Tourette Syndrome Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Tourette Syndrome Treatment Revenue in 2021
3.5 Tourette Syndrome Treatment Key Players Head office and Area Served
3.6 Key Players Tourette Syndrome Treatment Product Solution and Service
3.7 Date of Enter into Tourette Syndrome Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Tourette Syndrome Treatment Breakdown Data by Type
4.1 Global Tourette Syndrome Treatment Historic Market Size by Type (2017-2022)
4.2 Global Tourette Syndrome Treatment Forecasted Market Size by Type (2023-2028)
5 Tourette Syndrome Treatment Breakdown Data by Application
5.1 Global Tourette Syndrome Treatment Historic Market Size by Application (2017-2022)
5.2 Global Tourette Syndrome Treatment Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Tourette Syndrome Treatment Market Size (2017-2028)
6.2 North America Tourette Syndrome Treatment Market Size by Type
6.2.1 North America Tourette Syndrome Treatment Market Size by Type (2017-2022)
6.2.2 North America Tourette Syndrome Treatment Market Size by Type (2023-2028)
6.2.3 North America Tourette Syndrome Treatment Market Share by Type (2017-2028)
6.3 North America Tourette Syndrome Treatment Market Size by Application
6.3.1 North America Tourette Syndrome Treatment Market Size by Application (2017-2022)
6.3.2 North America Tourette Syndrome Treatment Market Size by Application (2023-2028)
6.3.3 North America Tourette Syndrome Treatment Market Share by Application (2017-2028)
6.4 North America Tourette Syndrome Treatment Market Size by Country
6.4.1 North America Tourette Syndrome Treatment Market Size by Country (2017-2022)
6.4.2 North America Tourette Syndrome Treatment Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Tourette Syndrome Treatment Market Size (2017-2028)
7.2 Europe Tourette Syndrome Treatment Market Size by Type
7.2.1 Europe Tourette Syndrome Treatment Market Size by Type (2017-2022)
7.2.2 Europe Tourette Syndrome Treatment Market Size by Type (2023-2028)
7.2.3 Europe Tourette Syndrome Treatment Market Share by Type (2017-2028)
7.3 Europe Tourette Syndrome Treatment Market Size by Application
7.3.1 Europe Tourette Syndrome Treatment Market Size by Application (2017-2022)
7.3.2 Europe Tourette Syndrome Treatment Market Size by Application (2023-2028)
7.3.3 Europe Tourette Syndrome Treatment Market Share by Application (2017-2028)
7.4 Europe Tourette Syndrome Treatment Market Size by Country
7.4.1 Europe Tourette Syndrome Treatment Market Size by Country (2017-2022)
7.4.2 Europe Tourette Syndrome Treatment Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Tourette Syndrome Treatment Market Size (2017-2028)
8.2 Asia-Pacific Tourette Syndrome Treatment Market Size by Type
8.2.1 Asia-Pacific Tourette Syndrome Treatment Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Tourette Syndrome Treatment Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Tourette Syndrome Treatment Market Share by Type (2017-2028)
8.3 Asia-Pacific Tourette Syndrome Treatment Market Size by Application
8.3.1 Asia-Pacific Tourette Syndrome Treatment Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Tourette Syndrome Treatment Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Tourette Syndrome Treatment Market Share by Application (2017-2028)
8.4 Asia-Pacific Tourette Syndrome Treatment Market Size by Region
8.4.1 Asia-Pacific Tourette Syndrome Treatment Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Tourette Syndrome Treatment Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Tourette Syndrome Treatment Market Size (2017-2028)
9.2 Latin America Tourette Syndrome Treatment Market Size by Type
9.2.1 Latin America Tourette Syndrome Treatment Market Size by Type (2017-2022)
9.2.2 Latin America Tourette Syndrome Treatment Market Size by Type (2023-2028)
9.2.3 Latin America Tourette Syndrome Treatment Market Share by Type (2017-2028)
9.3 Latin America Tourette Syndrome Treatment Market Size by Application
9.3.1 Latin America Tourette Syndrome Treatment Market Size by Application (2017-2022)
9.3.2 Latin America Tourette Syndrome Treatment Market Size by Application (2023-2028)
9.3.3 Latin America Tourette Syndrome Treatment Market Share by Application (2017-2028)
9.4 Latin America Tourette Syndrome Treatment Market Size by Country
9.4.1 Latin America Tourette Syndrome Treatment Market Size by Country (2017-2022)
9.4.2 Latin America Tourette Syndrome Treatment Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Tourette Syndrome Treatment Market Size (2017-2028)
10.2 Middle East & Africa Tourette Syndrome Treatment Market Size by Type
10.2.1 Middle East & Africa Tourette Syndrome Treatment Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Tourette Syndrome Treatment Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Tourette Syndrome Treatment Market Share by Type (2017-2028)
10.3 Middle East & Africa Tourette Syndrome Treatment Market Size by Application
10.3.1 Middle East & Africa Tourette Syndrome Treatment Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Tourette Syndrome Treatment Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Tourette Syndrome Treatment Market Share by Application (2017-2028)
10.4 Middle East & Africa Tourette Syndrome Treatment Market Size by Country
10.4.1 Middle East & Africa Tourette Syndrome Treatment Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Tourette Syndrome Treatment Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 AstraZeneca
11.1.1 AstraZeneca Company Details
11.1.2 AstraZeneca Business Overview
11.1.3 AstraZeneca Tourette Syndrome Treatment Introduction
11.1.4 AstraZeneca Revenue in Tourette Syndrome Treatment Business (2017-2022)
11.1.5 AstraZeneca Recent Developments
11.2 Boehringer Ingelheim International GmbH
11.2.1 Boehringer Ingelheim International GmbH Company Details
11.2.2 Boehringer Ingelheim International GmbH Business Overview
11.2.3 Boehringer Ingelheim International GmbH Tourette Syndrome Treatment Introduction
11.2.4 Boehringer Ingelheim International GmbH Revenue in Tourette Syndrome Treatment Business (2017-2022)
11.2.5 Boehringer Ingelheim International GmbH Recent Developments
11.3 Eli Lilly and Co.
11.3.1 Eli Lilly and Co. Company Details
11.3.2 Eli Lilly and Co. Business Overview
11.3.3 Eli Lilly and Co. Tourette Syndrome Treatment Introduction
11.3.4 Eli Lilly and Co. Revenue in Tourette Syndrome Treatment Business (2017-2022)
11.3.5 Eli Lilly and Co. Recent Developments
11.4 Mylan NV
11.4.1 Mylan NV Company Details
11.4.2 Mylan NV Business Overview
11.4.3 Mylan NV Tourette Syndrome Treatment Introduction
11.4.4 Mylan NV Revenue in Tourette Syndrome Treatment Business (2017-2022)
11.4.5 Mylan NV Recent Developments
11.5 Otsuka Holdings Co. Ltd.
11.5.1 Otsuka Holdings Co. Ltd. Company Details
11.5.2 Otsuka Holdings Co. Ltd. Business Overview
11.5.3 Otsuka Holdings Co. Ltd. Tourette Syndrome Treatment Introduction
11.5.4 Otsuka Holdings Co. Ltd. Revenue in Tourette Syndrome Treatment Business (2017-2022)
11.5.5 Otsuka Holdings Co. Ltd. Recent Developments
11.6 Sanofi S.A.
11.6.1 Sanofi S.A. Company Details
11.6.2 Sanofi S.A. Business Overview
11.6.3 Sanofi S.A. Tourette Syndrome Treatment Introduction
11.6.4 Sanofi S.A. Revenue in Tourette Syndrome Treatment Business (2017-2022)
11.6.5 Sanofi S.A. Recent Developments
11.7 Pfizer Inc.
11.7.1 Pfizer Inc. Company Details
11.7.2 Pfizer Inc. Business Overview
11.7.3 Pfizer Inc. Tourette Syndrome Treatment Introduction
11.7.4 Pfizer Inc. Revenue in Tourette Syndrome Treatment Business (2017-2022)
11.7.5 Pfizer Inc. Recent Developments
11.8 Sun Pharmaceutical Industries Ltd
11.8.1 Sun Pharmaceutical Industries Ltd Company Details
11.8.2 Sun Pharmaceutical Industries Ltd Business Overview
11.8.3 Sun Pharmaceutical Industries Ltd Tourette Syndrome Treatment Introduction
11.8.4 Sun Pharmaceutical Industries Ltd Revenue in Tourette Syndrome Treatment Business (2017-2022)
11.8.5 Sun Pharmaceutical Industries Ltd Recent Developments
11.9 Neurocrine Biosciences, Inc.
11.9.1 Neurocrine Biosciences, Inc. Company Details
11.9.2 Neurocrine Biosciences, Inc. Business Overview
11.9.3 Neurocrine Biosciences, Inc. Tourette Syndrome Treatment Introduction
11.9.4 Neurocrine Biosciences, Inc. Revenue in Tourette Syndrome Treatment Business (2017-2022)
11.9.5 Neurocrine Biosciences, Inc. Recent Developments
11.10 Novartis AG
11.10.1 Novartis AG Company Details
11.10.2 Novartis AG Business Overview
11.10.3 Novartis AG Tourette Syndrome Treatment Introduction
11.10.4 Novartis AG Revenue in Tourette Syndrome Treatment Business (2017-2022)
11.10.5 Novartis AG Recent Developments
11.11 Teva Pharmaceutical Industries Ltd.
11.11.1 Teva Pharmaceutical Industries Ltd. Company Details
11.11.2 Teva Pharmaceutical Industries Ltd. Business Overview
11.11.3 Teva Pharmaceutical Industries Ltd. Tourette Syndrome Treatment Introduction
11.11.4 Teva Pharmaceutical Industries Ltd. Revenue in Tourette Syndrome Treatment Business (2017-2022)
11.11.5 Teva Pharmaceutical Industries Ltd. Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer